Sara-Bay Financial’s Krystal Biotech KRYS Stock Holding History

Sara-Bay Financial’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Buy	+665	New	+$199K	0.07%	79

Other funds holding KRYS

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Sara-Bay Financial's KRYS Position: Q2 2026 in Review

Sara-Bay Financial opened a new position in Krystal Biotech (KRYS) in Q2 2026: 665 shares worth $247K. The stake represents 0.07% of the portfolio and ranks #79 among its holdings.

74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Sara-Bay Financial held 665 shares of Krystal Biotech worth $247K as of Q2 2026.
Krystal Biotech was a new Sara-Bay Financial position in Q2 2026.
Krystal Biotech made up 0.07% of Sara-Bay Financial's portfolio in Q2 2026, its #79 holding.
74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Sara-Bay Financial's 13F filing for Q2 2026, filed 17 Jul 2026.